British National Lymphoma Investigation: Pilot Studies of Neoadjuvant Chemotherapy in Clinical Stage Ia and IIa Hodgkin's Disease
- 31 August 2001
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 13 (4) , 262-268
- https://doi.org/10.1053/clon.2001.9265
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden HospitalBritish Journal of Cancer, 1997
- Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionationRadiotherapy and Oncology, 1995
- Efficacy and toxicity of vinblastine, bleomycin, and methotrexate with involved-field radiotherapy in clinical stage IA and IIA Hodgkin's disease: a British National Lymphoma Investigation pilot study.Journal of Clinical Oncology, 1994
- Radiation therapy in clinical stage I and II Hodgkin's diseaseEuropean Journal Of Cancer, 1992
- Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.BMJ, 1992
- Coronary artery disease mortality in patients treated for hodgkin's diseaseCancer, 1992
- Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease.Journal of Clinical Oncology, 1988
- REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEXThe Lancet, 1985
- The place of radiotherapy in the management of localised Hodgkin's disease (report no 11)Clinical Radiology, 1981
- Long-term results of the E.O.R.T.C. randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin's diseasePublished by Elsevier ,1979